Stefania Kapetanaki
Stefania Kapetanaki Befattning: - Organisation: Institutionen för medicinska vetenskaperE-post: c3RlZmFuaWEua2FwZXRhbmFraTtvcnUuc2U=
Telefon: 019 302192
Rum: X3209
Publikationer
Artiklar i tidskrifter |
Doktorsavhandlingar, sammanläggningar |
Manuskript |
Artiklar i tidskrifter
- Kapetanaki, S. , Kumawat, A. K. , Paramel Varghese, G. , Persson, K. & Demirel, I. (2024). TMAO enhances TNF-α mediated fibrosis and release of inflammatory mediators from renal fibroblasts. Scientific Reports, 14 (1). [BibTeX]
- Kapetanaki, S. , Kumawat, A. K. , Persson, K. & Demirel, I. (2022). TMAO Suppresses Megalin Expression and Albumin Uptake in Human Proximal Tubular Cells Via PI3K and ERK Signaling. International Journal of Molecular Sciences, 23 (16). [BibTeX]
- Kapetanaki, S. , Kumawat, A. K. , Persson, K. & Demirel, I. (2021). The Fibrotic Effects of TMAO on Human Renal Fibroblasts Is Mediated by NLRP3, Caspase-1 and the PERK/Akt/mTOR Pathway. International Journal of Molecular Sciences, 22 (21). [BibTeX]
Doktorsavhandlingar, sammanläggningar
- Kapetanaki, S. (2024). The role of TMAO in renal interstitium and chronic kidney disease. (Doctoral dissertation). (Sammanläggning) Örebro: Örebro University. [BibTeX]
Manuskript
- Kapetanaki, S. , Salihovic, S. , Kumawat, A. K. , Persson, K. , Barany, P. , Stenvinkel, P. , Evans, M. & Demirel, I. Correlations between Trimethylamine-N-oxide, megalin, lysine and markers of tubular damage in chronic kidney disease. [BibTeX]